REG-BARCLAYS PLC FORM 8.3 - WILLIS TOWERS WATSON PLC Amendment
25/02/2021 09:20
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210225:nBw2QPvrsa&default-theme=true
FORM 8.3 - WILLIS TOWERS WATSON PLC Amendment
Ap19
FORM 8.3 Amendment to sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 22 February 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,035,360 1.58% 383,076 0.30%
(2) Derivatives (other than options):
153,127 0.12% 240,989 0.19%
(3) Options and agreements to
purchase/sell: 6,000 0.00% 6,000 0.00%
TOTAL:
2,194,487 1.70% 630,065 0.49%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 225.0000 USD
Purchase 7 225.1828 USD
Purchase 7 225.0786 USD
Purchase 11 224.9400 USD
Purchase 25 225.3900 USD
Purchase 40 225.3600 USD
Purchase 50 225.3800 USD
Purchase 89 225.4496 USD
Purchase 100 224.8600 USD
Purchase 121 225.3205 USD
Purchase 144 224.9165 USD
Purchase 150 225.0266 USD
Purchase 169 225.2630 USD
Purchase 199 225.3590 USD
Purchase 300 225.3500 USD
Purchase 400 225.1587 USD
Purchase 586 225.1299 USD
Purchase 952 224.9192 USD
Purchase 994 224.9456 USD
Purchase 994 224.9455 USD
Purchase 1,200 225.2399 USD
Purchase 2,530 225.1243 USD
Purchase 2,907 225.1740 USD
Purchase 3,783 225.1634 USD
Purchase 7,419 225.1151 USD
Purchase 12,824 225.2428 USD
Purchase 13,240 225.0212 USD
Purchase 13,618 225.0062 USD
Purchase 28,276 225.0324 USD
Purchase 102,625 224.9004 USD
Purchase 108,853 224.9000 USD
Sale 1 225.2800 USD
Sale 1 225.2600 USD
Sale 2 225.1700 USD
Sale 25 225.3900 USD
Sale 49 224.9500 USD
Sale 87 225.4600 USD
Sale 100 224.9900 USD
Sale 100 224.7300 USD
Sale 100 224.8100 USD
Sale 200 225.1900 USD
Sale 238 224.7843 USD
Sale 256 225.5798 USD
Sale 294 224.8823 USD
Sale 302 225.1451 USD
Sale 437 225.1458 USD
Sale 488 224.9858 USD
Sale 493 224.9178 USD
Sale 700 224.9721 USD
Sale 710 225.1486 USD
Sale 916 224.9789 USD
Sale 952 224.9192 USD
Sale 994 224.9455 USD
Sale 1,037 224.9839 USD
Sale 1,200 225.2399 USD
Sale 1,369 224.9023 USD
Sale 1,820 225.0701 USD
Sale 3,124 225.1192 USD
Sale 4,295 225.1032 USD
Sale 4,927 224.9272 USD
Sale 5,839 224.8999 USD
Sale 8,326 224.9723 USD
Sale 10,000 225.1619 USD
Sale 10,352 225.1347 USD
Sale 11,723 225.0187 USD
Sale 12,669 224.9952 USD
Sale 12,845 225.2718 USD
Sale 102,555 224.9000 USD
Sale 102,626 224.9004 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 25 Feb 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210225005400/en/
(https://www.businesswire.com/news/home/20210225005400/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Inter-American Dev - Issue of Debt
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC JTC PLC - Form 8.3 JTC PLC
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
Announcement